BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11913731)

  • 1. Genetic and Epigenetic Markers of Lithium Response.
    Pisanu C; Meloni A; Severino G; Squassina A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives.
    Senner F; Kohshour MO; Abdalla S; Papiol S; Schulze TG
    Front Pharmacol; 2021; 12():638882. PubMed ID: 33867988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of response to drug therapy in psychiatric disorders.
    Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH
    Open Biol; 2018 May; 8(5):. PubMed ID: 29794033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
    Pisanu C; Heilbronner U; Squassina A
    Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
    Amare AT; Schubert KO; Baune BT
    EPMA J; 2017 Sep; 8(3):211-227. PubMed ID: 29021832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
    Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
    Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
    Alda M
    Mol Psychiatry; 2015 Jun; 20(6):661-70. PubMed ID: 25687772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to lithium in bipolar disorder: clinical and genetic findings.
    Rybakowski JK
    ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular actions and clinical pharmacogenetics of lithium therapy.
    Can A; Schulze TG; Gould TD
    Pharmacol Biochem Behav; 2014 Aug; 123():3-16. PubMed ID: 24534415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of lithium response in bipolar disorder.
    Tighe SK; Mahon PB; Potash JB
    Ther Adv Chronic Dis; 2011 May; 2(3):209-26. PubMed ID: 23251751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.
    Squassina A; Manchia M; Del Zompo M
    Hum Genomics Proteomics; 2010 Aug; 2010():159761. PubMed ID: 20981231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise and reality of pharmacogenetics in psychiatry.
    Zandi PP; Judy JT
    Psychiatr Clin North Am; 2010 Mar; 33(1):181-224. PubMed ID: 20159346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium: a key to the genetics of bipolar disorder.
    Cruceanu C; Alda M; Turecki G
    Genome Med; 2009 Aug; 1(8):79. PubMed ID: 19691823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics in mood disorder.
    Nnadi CU; Goldberg JF; Malhotra AK
    Curr Opin Psychiatry; 2005 Jan; 18(1):33-9. PubMed ID: 16639181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.
    Mamdani F; Jaitovich Groisman I; Alda M; Turecki G
    Curr Psychiatry Rep; 2003 Dec; 5(6):484-92. PubMed ID: 14609504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Mandelli L; Lorenzi C; Smeraldi E
    Pharmacogenomics J; 2001; 1(1):71-7. PubMed ID: 11913731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders.
    Seretti A; Cusin C; Lattuada E; Di Bella D; Catalano M; Smeraldi E
    Mol Psychiatry; 1999 May; 4(3):280-3. PubMed ID: 10395220
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.